Meningeal myeloma in the absence of systemic disease, and as the initial feature of disease progression. Clin Lab Haematol 1998 Jun;20(3):189-90
Date
07/29/1998Pubmed ID
9681237DOI
10.1046/j.1365-2257.1998.00106.xScopus ID
2-s2.0-0031810257 (requires institutional sign-in at Scopus site) 5 CitationsAbstract
We describe a 60-year-old man with stage IIA myeloma, who despite achieving a systemic remission after C-VAMP, progressed with isolated meningeal myeloma. Meningeal involvement in myeloma is a rare complication with a poor prognosis.
Author List
Somers LJ, Shaw B, Lyn BE, McMillan AM, Mahendra PAuthor
Bronwen E. Shaw MBChB, PhD Center Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antineoplastic Combined Chemotherapy ProtocolsBone Neoplasms
Combined Modality Therapy
Cranial Irradiation
Cyclophosphamide
Disease Progression
Doxorubicin
Fatal Outcome
Hematopoietic Stem Cell Transplantation
Humans
Immunoglobulin G
Immunoglobulin lambda-Chains
Injections, Spinal
Male
Meningeal Neoplasms
Methotrexate
Methylprednisolone
Middle Aged
Multiple Myeloma
Myeloma Proteins
Neoplasm Staging
Ribs
Vincristine
